TransMedics Group, Inc. TMDX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $173.93M+21.2% | $160.76M+32.2% | $143.82M+32.2% | $157.37M+37.7% | $143.54M+48.2% | ||
| $72.77M+31.6% | $67.35M+35.8% | $59.25M+23.6% | $60.78M+34.9% | $55.31M+49.9% | ||
| $101.16M+14.7% | $93.41M+29.7% | $84.58M+39.0% | $96.59M+39.5% | $88.23M+47.1% | ||
| 58.2%-3.3pp | 58.1%-1.1pp | 58.8%+2.9pp | 61.4%+0.8pp | 61.5%-0.4pp | ||
| $24.88M+45.0% | $20.7M+25.7% | $15.26M+7.0% | $15.93M+15.0% | $17.16M+50.8% | ||
| $62.99M+44.4% | $51.44M+9.7% | $46.02M+7.9% | $44.09M+2.8% | $43.63M+20.6% | ||
| $87.86M+44.5% | $72.14M+13.8% | $61.28M+7.6% | $60.02M+5.8% | $60.79M+27.9% | ||
| $87.86M+44.5% | $72.14M+13.8% | $61.28M+7.6% | $60.02M+5.8% | $60.79M+27.9% | ||
| $13.3M-51.5% | $21.27M+146% | $23.3M+494% | $36.57M+192% | $27.44M+121% | ||
| 7.6%-11.5pp | 13.2%+6.1pp | 16.2%+12.6pp | 23.2%+12.3pp | 19.1%+6.3pp | ||
| $7.17M+107% | $3.35M-6.1% | $3.49M-3.5% | $3.48M-4.1% | $3.46M-3.8% | ||
| -$4.81M-527% | —— | -$269K-184% | -$385K-8.5% | -$767K-2,639% | ||
| $8.49M-68.2% | $21.63M+210% | $23.03M+443% | $36.18M+198% | $26.68M+115% | ||
| $1.17M+17.7% | -$83.75M-63,547% | -$1.29M-4,541% | $1.28M+3,210% | $994K+407% | ||
| $7.32M-71.5% | $105.38M+1,437% | $24.32M+477% | $34.91M+186% | $25.68M+111% | ||
| 4.2%-13.7pp | 65.6%+59.9pp | 16.9%+13.0pp | 22.2%+11.5pp | 17.9%+5.3pp | ||
| $0.20-71.4% | $2.59+1,195% | $0.66+450% | $0.92+163% | $0.70+100% | ||
| $0.21-72.4% | $3.10+1,376% | $0.71+446% | $1.03+178% | $0.76+105% | ||
| 36.2M-9.3% | 40.5M+15.1% | 40.7M+14.2% | 40.6M+14.9% | 39.9M+15.1% | ||
| 34.4M+2.0% | 34M+2.3% | 34.1M+2.0% | 33.9M+2.4% | 33.7M+2.9% | ||
| $2.36M-12.5% | $3.71M+93.8% | $3.22M-18.2% | $3.09M-5.4% | $2.69M-24.5% | ||
| $13.3M-51.5% | $21.27M+146% | $23.3M+494% | $36.57M+192% | $27.44M+121% | ||
| $25.16M-25.1% | $28.74M+101% | $30.15M+231% | $43.3M+153% | $33.58M+101% | ||
| $25.16M-25.1% | $28.74M+101% | $30.15M+231% | $43.3M+153% | $33.58M+101% | ||
| 14.5%-8.9pp | 17.9%+6.1pp | 21%+12.6pp | 27.5%+12.5pp | 23.4%+6.1pp | ||
| $13.3M-51.5% | $21.27M+146% | $23.3M+494% | $36.57M+192% | $27.44M+121% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TransMedics Group, Inc.'s revenue?
- TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.
- Is TransMedics Group, Inc. profitable?
- TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.
- What are TransMedics Group, Inc.'s profit margins?
- Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.
- What is TransMedics Group, Inc.'s earnings per share?
- TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.
- Where does TransMedics Group, Inc.'s income statement data come from?
- Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
